Proteins

Items 81-90 of 106

per page
Set Descending Direction
  1. LAG-3 (mouse):Fc (mouse) (rec.)
    AG-40B-0039
    AG-40B-0039-C05050 µg
    CHF 410.00
  2. LIF (human) (rec.)
    AG-40B-0093
    AG-40B-0093-C01010 µg
    CHF 170.00
    AG-40B-0093-30103 x 10 µg
    CHF 335.00
    AG-40B-0093-C100100 µg
    CHF 1'010.00
    Figure: Human Leukemia Inhibitory Factor (LIF) (rec.) (AG-40B-0093) maintains pluripotency of mouse ES cells. Method: Mouse ES oct4 GFP cells were cultured for 3 days in the presence of the indicated concentrations of LIF and followed
  3. LIGHT, Soluble (human) (rec.)
    AG-40B-0009
    AG-40B-0009-C01010 µg
    CHF 145.00
    AG-40B-0009-30103 x 10 µg
    CHF 290.00
  4. Netrin-1 (human) (rec.)
    AG-40B-0040
    AG-40B-0040-C01010 µg
    CHF 300.00
    AG-40B-0040-30103 x 10 µg
    CHF 600.00
    AG-40B-0040-C100100 µg
    CHF 1'320.00
  5. Netrin-1 (human):Fc (human) (rec.)
    AG-40B-0075
    AG-40B-0075-C01010 µg
    CHF 350.00
    AG-40B-0075-30103 x 10 µg
    CHF 695.00
    AG-40B-0075-C100100 µg
    CHF 1'560.00
    Netrin-1 (human):Fc (human) (rec.) (Prod. No. AG-40B-0075) triggers a DCC-dependent phosphorylation of ERK1/2. Method: HEK 293 cells (Control) or HEK 293 expressing the netrin-1 receptor DCC were incubated with netrin-1 (human):Fc (
  6. Notch1 (mouse):Fc (human) (rec.)
    AG-40B-0109
    AG-40B-0109-C05050 µg
    CHF 290.00
    AG-40B-0109-30503 x 50 µg
    CHF 575.00
  7. Notch2 (mouse):Fc (human) (rec.)
    AG-40B-0110
    AG-40B-0110-C05050 µg
    CHF 290.00
    AG-40B-0110-30503 x 50 µg
    CHF 575.00
  8. OX40 (human):Fc (human) (rec.)
    AG-40B-0014
    AG-40B-0014-C05050 µg
    CHF 215.00
    AG-40B-0014-30503 x 50 µg
    CHF 430.00
  9. OX40L (mouse) (multimeric) (rec.)
    AG-40B-0029
    AG-40B-0029-C01010 µg
    CHF 220.00
  10. PARP-2 [ARTD2] (mouse) (rec.) (His) (high purity)
    AG-40T-0012
    AG-40T-0012-C01010 µg
    CHF 390.00

Items 81-90 of 106

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.